Table 1 The quality outcomes of assessed clinical studies that were included

Chevalier [19]

2

2

1

0

5

Cardiac death, overall mortality, MI, TLR, TVR, ST, LLL

Byrne [20]

2

2

2

1

7

Overall mortality, MI, TLR, ST, LLL

Chevalier [21]

2

2

1

1

6

Cardiac death, overall mortality, MI, TLR, TVR, ST, LLL

Stefanini [22]

2

2

2

1

7

Cardiac death, overall mortality, MI, TLR, TVR, ST

Byrne [23]

2

2

2

1

7

Cardiac death, overall mortality, MI, TLR, ST

Maamoun [24]

1

1

0

1

3

Cardiac death, overall mortality, MI, TLR, ST

Kadota [25]

1

1

0

1

3

Cardiac death, overall mortality, MI, TLR, TVR, ST, LLL

Xu [26]

1

1

2

0

4

Cardiac death, overall mortality, MI, TLR, ST, LLL

Tan [27]

1

1

2

1

5

Cardiac death, overall mortality, MI, TLR, TVR, ST

Ge [28]

1

1

0

1

3

Cardiac death, MI, TVR, ST

Smits [29]

2

2

0

0

4

Cardiac death, overall mortality, MI, TVR, TLR, ST

Zhang [30]

2

2

1

1

6

Cardiac death, overall mortality, MI, TVR, TLR, ST

Natsuaki [31]

2

2

0

0

4

Cardiac death, overall mortality, MI, TVR, TLR, ST

Raungaard [32]

2

2

0

0

4

Cardiac death, overall mortality, MI, TVR, TLR, ST

Han [33]

2

1

1

1

5

Cardiac death, overall mortality, MI, TVR, TLR, ST

Pilgrim [34]

2

2

2

0

6

Cardiac death, overall mortality, MI, TVR, TLR, ST